The CD4 + CD25 -, CD45RA +, CD45RO +, and CD4 + CD45RO + CD25 - were able to significantly induce FOXP3 mRNA up to 30 - fold upon TCR activation and addition of TGF - beta.	"CD4	4	7	Protein"	"CD25	10	14	Protein"	"CD45RA	18	24	Protein"	"CD45RO	28	34	Protein"	"CD4	42	45	Protein"	"CD45RO	48	54	Protein"	"CD25	57	61	Protein"	"FOXP3	98	103	Protein"	"TGF - beta	161	171	Protein"	"[{""token"": ""CD4"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Protein""}, {""token"": ""CD25"", ""start_span"": 10, ""end_span"": 14, ""type"": ""Protein""}, {""token"": ""CD45RA"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Protein""}, {""token"": ""CD45RO"", ""start_span"": 28, ""end_span"": 34, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Protein""}, {""token"": ""CD45RO"", ""start_span"": 48, ""end_span"": 54, ""type"": ""Protein""}, {""token"": ""CD25"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Protein""}, {""token"": ""FOXP3"", ""start_span"": 98, ""end_span"": 103, ""type"": ""Protein""}, {""token"": ""TGF - beta"", ""start_span"": 161, ""end_span"": 171, ""type"": ""Protein""}]"
Upon administration of rmIL - 4 plus anti - IL - 4 mAb complexes, the total number of CD4 + CD25 + T cell, as well as the Foxp3 + T cells diminished by half ( Figure S2G and S2H), confirming that the lower percentage was not due to an increase in the CD4 + CD25 - cells, but a real decrease of CD4 + CD25 + T cells.	"rmIL - 4	23	31	Protein"	"IL - 4	44	50	Protein"	"CD4	86	89	Protein"	"CD25	92	96	Protein"	"Foxp3	122	127	Protein"	"CD4	251	254	Protein"	"CD25	257	261	Protein"	"CD4	294	297	Protein"	"CD25	300	304	Protein"	"[{""token"": ""rmIL - 4"", ""start_span"": 23, ""end_span"": 31, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 44, ""end_span"": 50, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Protein""}, {""token"": ""CD25"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Protein""}, {""token"": ""Foxp3"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 251, ""end_span"": 254, ""type"": ""Protein""}, {""token"": ""CD25"", ""start_span"": 257, ""end_span"": 261, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 294, ""end_span"": 297, ""type"": ""Protein""}, {""token"": ""CD25"", ""start_span"": 300, ""end_span"": 304, ""type"": ""Protein""}]"
CD4 + T cells were gated on the basis of CD45RO and CD25 surface expression ( upper panel), and gated cells are shown below for the CD45RO + CD25 - ( A, left panel), the CD45RO + CD25 + ( right panel), and the CD45RO - CD25 - subsets ( central panel).	"CD4	0	3	Protein"	"CD45RO	41	47	Protein"	"CD25	52	56	Protein"	"CD45RO	132	138	Protein"	"CD25	141	145	Protein"	"CD45RO	170	176	Protein"	"CD25	179	183	Protein"	"CD45RO	210	216	Protein"	"CD25	219	223	Protein"	"[{""token"": ""CD4"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Protein""}, {""token"": ""CD45RO"", ""start_span"": 41, ""end_span"": 47, ""type"": ""Protein""}, {""token"": ""CD25"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Protein""}, {""token"": ""CD45RO"", ""start_span"": 132, ""end_span"": 138, ""type"": ""Protein""}, {""token"": ""CD25"", ""start_span"": 141, ""end_span"": 145, ""type"": ""Protein""}, {""token"": ""CD45RO"", ""start_span"": 170, ""end_span"": 176, ""type"": ""Protein""}, {""token"": ""CD25"", ""start_span"": 179, ""end_span"": 183, ""type"": ""Protein""}, {""token"": ""CD45RO"", ""start_span"": 210, ""end_span"": 216, ""type"": ""Protein""}, {""token"": ""CD25"", ""start_span"": 219, ""end_span"": 223, ""type"": ""Protein""}]"
Human CD4 + CD127 - CD25high and CD4 + CD127 + CD25neg cells were purified by flow cytometry using anti - CD127, anti - CD25 - PC5 ( Beckman Coulter), and anti - CD4 - FITC antibodies ( Dako).	"CD4	6	9	Protein"	"CD127	12	17	Protein"	"CD25high	20	28	Protein"	"CD4	33	36	Protein"	"CD127	39	44	Protein"	"CD25neg	47	54	Protein"	"CD127	106	111	Protein"	"CD25	120	124	Protein"	"CD4	162	165	Protein"	"[{""token"": ""CD4"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Protein""}, {""token"": ""CD127"", ""start_span"": 12, ""end_span"": 17, ""type"": ""Protein""}, {""token"": ""CD25high"", ""start_span"": 20, ""end_span"": 28, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Protein""}, {""token"": ""CD127"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Protein""}, {""token"": ""CD25neg"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Protein""}, {""token"": ""CD127"", ""start_span"": 106, ""end_span"": 111, ""type"": ""Protein""}, {""token"": ""CD25"", ""start_span"": 120, ""end_span"": 124, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 162, ""end_span"": 165, ""type"": ""Protein""}]"
( A) RUNX1, RUNX3, and FOXP3 mRNA induction in human naive CD4 + T cells after alone or combined anti - CD2 / 3 / 28 mAb and TGF - beta stimulation in the presence of IL - 2.	"RUNX1	5	10	Protein"	"RUNX3	12	17	Protein"	"FOXP3	23	28	Protein"	"CD4	59	62	Protein"	"CD2	104	107	Protein"	"3	110	111	Protein"	"28	114	116	Protein"	"TGF - beta	125	135	Protein"	"IL - 2	167	173	Protein"	"[{""token"": ""RUNX1"", ""start_span"": 5, ""end_span"": 10, ""type"": ""Protein""}, {""token"": ""RUNX3"", ""start_span"": 12, ""end_span"": 17, ""type"": ""Protein""}, {""token"": ""FOXP3"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Protein""}, {""token"": ""CD2"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Protein""}, {""token"": ""3"", ""start_span"": 110, ""end_span"": 111, ""type"": ""Protein""}, {""token"": ""28"", ""start_span"": 114, ""end_span"": 116, ""type"": ""Protein""}, {""token"": ""TGF - beta"", ""start_span"": 125, ""end_span"": 135, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 167, ""end_span"": 173, ""type"": ""Protein""}]"
Real - time PCR for FOXP3, T - bet, GATA3, and RORC2 from human naive CD4 + T cells, transfected with RUNX1 and RUNX3 siRNA or with scrambled siRNA ( control) and cultured under iT reg, Th1, Th2, or Th17 - driving conditions for 12 d.	"FOXP3	20	25	Protein"	"T - bet	27	34	Protein"	"GATA3	36	41	Protein"	"RORC2	47	52	Protein"	"CD4	70	73	Protein"	"RUNX1	102	107	Protein"	"RUNX3	112	117	Protein"	"iT reg	178	184	Protein"	"Th17	199	203	Protein"	"[{""token"": ""FOXP3"", ""start_span"": 20, ""end_span"": 25, ""type"": ""Protein""}, {""token"": ""T - bet"", ""start_span"": 27, ""end_span"": 34, ""type"": ""Protein""}, {""token"": ""GATA3"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Protein""}, {""token"": ""RORC2"", ""start_span"": 47, ""end_span"": 52, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Protein""}, {""token"": ""RUNX1"", ""start_span"": 102, ""end_span"": 107, ""type"": ""Protein""}, {""token"": ""RUNX3"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Protein""}, {""token"": ""iT reg"", ""start_span"": 178, ""end_span"": 184, ""type"": ""Protein""}, {""token"": ""Th17"", ""start_span"": 199, ""end_span"": 203, ""type"": ""Protein""}]"
Coimmunoprecipitation of IkappaB - alpha with p65 was detected at 0 - and 240 - min post - treatment in Tat - negative cells ( Figure 2D, lanes 1 and 3), and was halved in Tat - positive cells, where Tat coimmunoprecipitated with IkappaB - alpha ( Figure 2D, lanes 2 and 4), indicating that Tat competed the IkappaB - alpha binding to p65.	"IkappaB - alpha	25	40	Protein"	"p65	46	49	Protein"	"Tat	104	107	Protein"	"Tat	172	175	Protein"	"Tat	200	203	Protein"	"IkappaB - alpha	230	245	Protein"	"Tat	291	294	Protein"	"IkappaB - alpha	308	323	Protein"	"p65	335	338	Protein"	"[{""token"": ""IkappaB - alpha"", ""start_span"": 25, ""end_span"": 40, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Protein""}, {""token"": ""Tat"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Protein""}, {""token"": ""Tat"", ""start_span"": 172, ""end_span"": 175, ""type"": ""Protein""}, {""token"": ""Tat"", ""start_span"": 200, ""end_span"": 203, ""type"": ""Protein""}, {""token"": ""IkappaB - alpha"", ""start_span"": 230, ""end_span"": 245, ""type"": ""Protein""}, {""token"": ""Tat"", ""start_span"": 291, ""end_span"": 294, ""type"": ""Protein""}, {""token"": ""IkappaB - alpha"", ""start_span"": 308, ""end_span"": 323, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 335, ""end_span"": 338, ""type"": ""Protein""}]"
Further, we analysed the Tat effect on the IkappaB - alpha repression of p65 transcriptional activity by transfecting p50 - / - p65 - / - MEFs with the NF - kappaB - Luc reporter together with expression vectors of p65 and IkappaB - alpha, in presence or absence of Tat.	"Tat	25	28	Protein"	"IkappaB - alpha	43	58	Protein"	"p65	73	76	Protein"	"p50	118	121	Protein"	"p65	128	131	Protein"	"Luc	166	169	Protein"	"p65	215	218	Protein"	"IkappaB - alpha	223	238	Protein"	"Tat	266	269	Protein"	"[{""token"": ""Tat"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Protein""}, {""token"": ""IkappaB - alpha"", ""start_span"": 43, ""end_span"": 58, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Protein""}, {""token"": ""p50"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 128, ""end_span"": 131, ""type"": ""Protein""}, {""token"": ""Luc"", ""start_span"": 166, ""end_span"": 169, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 215, ""end_span"": 218, ""type"": ""Protein""}, {""token"": ""IkappaB - alpha"", ""start_span"": 223, ""end_span"": 238, ""type"": ""Protein""}, {""token"": ""Tat"", ""start_span"": 266, ""end_span"": 269, ""type"": ""Protein""}]"
Similarly to MIP - 1alpha, Tat increased the recruitment of p65 to the NF - kappaB enhancers of CSF3, LTA, NFKBIA and TLR2, while it was ineffective at the promoters of GAPDH and ACTB ( Figure 5H).	"MIP - 1alpha	13	25	Protein"	"Tat	27	30	Protein"	"p65	60	63	Protein"	"CSF3	96	100	Protein"	"LTA	102	105	Protein"	"NFKBIA	107	113	Protein"	"TLR2	118	122	Protein"	"GAPDH	169	174	Protein"	"ACTB	179	183	Protein"	"[{""token"": ""MIP - 1alpha"", ""start_span"": 13, ""end_span"": 25, ""type"": ""Protein""}, {""token"": ""Tat"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 60, ""end_span"": 63, ""type"": ""Protein""}, {""token"": ""CSF3"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Protein""}, {""token"": ""LTA"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Protein""}, {""token"": ""NFKBIA"", ""start_span"": 107, ""end_span"": 113, ""type"": ""Protein""}, {""token"": ""TLR2"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Protein""}, {""token"": ""GAPDH"", ""start_span"": 169, ""end_span"": 174, ""type"": ""Protein""}, {""token"": ""ACTB"", ""start_span"": 179, ""end_span"": 183, ""type"": ""Protein""}]"
